Open Forum: Key Issues in TB Drug Development

This two-day Open Forum is the third in a series of meetings aimed to
raise and address key issues in TB drug development, with a special
focus on regulatory affairs.

5-6 May 2008
New Delhi, India

This Forum will provide an arena for participants to share
information on, and discuss the various challenges regarding the
development and registration of new anti-TB drugs and regimens.
Building on topics discussed at the first and second Open Fora, Open
Forum 3 will focus largely on regulatory issues for new TB drugs in
development.

Some planned topics include: the current global TB drug development
portfolio, key issues in the critical path to TB drug registration,
designing pivotal trials, conducting registration trials in high
burden countries, challenges in TB drug development for resistant
disease and developing regimens containing multiple novel agents. As
this year's forum will take place in India, there will be a regional
focus on regulatory issues in Asia. This series of meetings are
designed to bring together regulators, TB drug developers and other
interested stakeholders, such as TB care providers, public health
policy-makers, and community advocates from both major industrialized
and high burden countries.

The Forum will include sessions on the current global TB drug
development portfolio, key issues in the critical path to TB drug
registration, designing pivotal trials, conducting registration
trials in high burden countries, challenges in TB drug development
for resistant disease and developing regimens containing multiple
novel agents.

These meetings are designed to bring together regulators, TB drug
developers and other interested stakeholders, such as TB care
providers, public health policy-makers, and community advocates from
both major industrialized and high burden countries.

For inquiries about this event, please contact:

rsvp@...

http://www.tballiance.org/events/openforum3.php